| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |